# Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

> **NCT01668121** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 48 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Symbicort Turbohaler
- **DRUG:** Budesonide/formoterol Easyhaler

## Key facts

- **NCT ID:** NCT01668121
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01668121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01668121, "Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01668121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*